中文 | English
Return
Total: 45 , 1/5
Show Home Prev Next End page: GO
Author:(Mao WEIMIN)

1.Status and role of p21cip1 for cancer biological therapy

Wenhu CHEN ; Weimin MAO

Cancer Research and Clinic 2009;21(3):212-215

2.EGFR-TKI in non-small cell lung cancer treatment

Weihui ZHENG ; Weimin MAO

Journal of International Oncology 2012;39(8):601-604

3.Therapeutic sensitivity gene SNP in esophageal cancer

Zhiqiang LING ; Weimin MAO

Journal of International Oncology 2011;38(12):923-926

4.Progression of microRNA in esophageal cancer

Jiangliu YU ; Zhiqiang LING ; Weimin MAO

Journal of International Oncology 2011;38(12):920-922

5.Single nucleotide polymorphisms of susceptibility gene in esophageal squamous cell carcinoma

Shizhou YANG ; Zhiqiang LING ; Weimin MAO

Journal of International Oncology 2011;38(12):917-919

6.Research progress of nimotuzumab in treatment of esophageal carcinoma

Xiao LIN ; Xiao ZHENG ; Weimin MAO

Cancer Research and Clinic 2015;(7):496-498

7.miR-21 in gastrointestinal cancer: research progresses

Jiamin YUAN ; Zhiqiang LING ; Weimin MAO

Journal of International Oncology 2011;38(1):45-48

8.hMSH6 polymorphisms and cancer susceptibility

Wei LIU ; Zhiqiang LING ; Weimin MAO

Journal of International Oncology 2011;38(4):243-245

9.Study on the Outcome of Acetabular Fractures Operative Treatment

Weimin MAO ; Rongming XU ; Yong HU

Journal of Chinese Physician 2001;0(04):-

10.Research progress of lymph node metastasis in esophageal cancer

Yinyin YING ; Yaping XU ; Weimin MAO

Journal of International Oncology 2014;41(12):921-925

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 45 , 1/5 Show Home Prev Next End page: GO